Matches in Wikidata for { <http://www.wikidata.org/entity/Q64397075> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q64397075 description "clinical trial" @default.
- Q64397075 description "ensayu clínicu" @default.
- Q64397075 description "klinisch onderzoek" @default.
- Q64397075 description "клінічне випробування" @default.
- Q64397075 description "կլինիկական փորձարկում" @default.
- Q64397075 name "A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis" @default.
- Q64397075 type Item @default.
- Q64397075 label "A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis" @default.
- Q64397075 prefLabel "A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis" @default.
- Q64397075 P1132 Q64397075-430B1CED-944E-4612-8A90-CD5F5A988C8F @default.
- Q64397075 P1476 Q64397075-DF711911-76C5-4E2D-B3E5-9EC851A446BD @default.
- Q64397075 P17 Q64397075-04E395AE-F9BD-4244-A432-3546E99CB2D5 @default.
- Q64397075 P17 Q64397075-0BD1B5B1-A773-4465-A0C1-984159BD632B @default.
- Q64397075 P17 Q64397075-196E96D3-D339-4986-9F9F-FEF85E714FDD @default.
- Q64397075 P17 Q64397075-276C7D9C-7FD3-4F7F-9EDC-34A0B2E66E11 @default.
- Q64397075 P17 Q64397075-499B5111-2225-46DA-A2D2-57B749659DE2 @default.
- Q64397075 P17 Q64397075-51A123B1-7E07-4129-B20A-BAAD49B6CFA4 @default.
- Q64397075 P17 Q64397075-6E9D6C43-9BA2-407E-B347-3E1E63CC4ECB @default.
- Q64397075 P17 Q64397075-73C5EE30-E5B6-47FA-A432-6CB3DE5E1828 @default.
- Q64397075 P17 Q64397075-7A3D4474-D34D-4B83-BCCC-A984A72EC959 @default.
- Q64397075 P17 Q64397075-832759C2-1E0D-45EF-BD43-AF53EC0D6C45 @default.
- Q64397075 P17 Q64397075-912B7BD9-71D7-45ED-B9B2-3B3EF15B539F @default.
- Q64397075 P17 Q64397075-B90CEA9E-C05B-4CC0-B65F-584B8E601BAF @default.
- Q64397075 P17 Q64397075-CA699055-ED58-4B26-8FBF-A12DC434B353 @default.
- Q64397075 P17 Q64397075-CB4C6EC5-ECF1-4C79-AF0B-62291523F155 @default.
- Q64397075 P17 Q64397075-F3426A9E-54FC-4D81-BA0A-F9054E00C277 @default.
- Q64397075 P17 Q64397075-F7CD43EB-1F2F-4163-B269-7CAC84F38C42 @default.
- Q64397075 P2899 Q64397075-BF069B99-E1B4-46AA-A96F-B35352CF84BB @default.
- Q64397075 P3098 Q64397075-7FC7DC48-6ADC-48F0-B5EE-3B1D9AB37446 @default.
- Q64397075 P31 Q64397075-12D88B18-B610-47CA-8D9E-A2B4ED4A1377 @default.
- Q64397075 P580 Q64397075-D8844143-41D5-4F82-9005-90CBEA07C4AD @default.
- Q64397075 P582 Q64397075-53CCCCD0-C24E-4A21-8FF8-6C578C048C00 @default.
- Q64397075 P6099 Q64397075-711A8F19-062E-4534-9EEC-FDF19FEBCC45 @default.
- Q64397075 P8363 Q64397075-63907D00-9812-4FD0-9440-A03BCFDB2335 @default.
- Q64397075 P1132 "+315" @default.
- Q64397075 P1476 "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Subjects With Active Radiographic Axial Spondyloarthritis" @default.
- Q64397075 P17 Q142 @default.
- Q64397075 P17 Q145 @default.
- Q64397075 P17 Q155 @default.
- Q64397075 P17 Q16 @default.
- Q64397075 P17 Q183 @default.
- Q64397075 P17 Q212 @default.
- Q64397075 P17 Q219 @default.
- Q64397075 P17 Q28 @default.
- Q64397075 P17 Q29 @default.
- Q64397075 P17 Q30 @default.
- Q64397075 P17 Q31 @default.
- Q64397075 P17 Q36 @default.
- Q64397075 P17 Q414 @default.
- Q64397075 P17 Q45 @default.
- Q64397075 P17 Q865 @default.
- Q64397075 P17 Q96 @default.
- Q64397075 P2899 "+18" @default.
- Q64397075 P3098 "NCT02438787" @default.
- Q64397075 P31 Q30612 @default.
- Q64397075 P580 "2015-07-31T00:00:00Z" @default.
- Q64397075 P582 "2017-08-31T00:00:00Z" @default.
- Q64397075 P6099 Q42824827 @default.
- Q64397075 P8363 Q78089383 @default.